• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Surviving a Merger: HBA Takes a Look

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001

Progress for women has always been on the agenda for the Healthcare Businesswomen}s Association. Founded in 1979, with almost 100 members, HBA is now more than 1,000 members strong. To support its commitment to the advancement of women in the healthcare industry, HBA has tracked key issues affecting women}s career development since 1997.

Articles in this issue
Overview of the Industry: A World of Opportunities
I Have A Dream: Communicating a Vision Helps Managers Become Leaders
Challenges to Diversity: Recruiting and Retaining Minorities
On the Right Path: Sales Careers in Pharma
Surviving a Merger: HBA Takes a Look
Related Videos
Related Content
Aspiring for the C-Suite? Consider Being a Chief of Staff

Aspiring for the C-Suite? Consider Being a Chief of Staff

April 12th 2024
Article

Why this role provides a critical ‘boot camp’ for future pharma leaders.

Straight and Simple Advice Lives On in the Pharma Industry

Straight and Simple Advice Lives On in the Pharma Industry

March 12th 2024
Article

Classic views on leadership are sometimes still the most effective.

Mike Hollan

It’s Always Important to Remember: Leaders Make Mistakes

December 12th 2023
Article

Continuous learning a vital skill for aspiring and established leaders alike.

Mike McCullar

Fighting Autoimmune Diseases and Developing Leadership Skills Along the Way: Q&A With Dr. Mike McCullar, CEO of RegCell

November 16th 2023
Article

McCullar discusses his new role as CEO of RegCell.

As Biopharma Firms Finalize C-Suite Goals for 2024, Are Their Workforces Prepared to Execute? A Q&A With MIT’s Stephanie L. Woerner, PhD

As Biopharma Firms Finalize C-Suite Goals for 2024, Are Their Workforces Prepared to Execute? A Q&A With MIT’s Stephanie L. Woerner, PhD

November 13th 2023
Article

C-Suites and their boards should remember that digital transformation is a key part of the larger focus of a profound business transformation.

Alliance for mRNA Medicines Launched to Advance the Promise of This Revolutionary Technology

Alliance for mRNA Medicines Launched to Advance the Promise of This Revolutionary Technology

November 1st 2023
Article

The Alliance for mRNA Medicines is the first and only scientific and policy organization singularly focused on advancing and advocating for global mRNA innovation.